Clinical trials and research studies

18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

MOVR:  Data Hub is the first and only data hub that aggregates clinical, genetic, and patient reported data for multiple nuromuscular diseases.  Collection of patient data about disease progression in the era of new treatments will inform and accelerate future innovation.  The combination of data collected through MOVR Data Hub will provide a comprehensive understanding of health and patient experiences in a single data repository.  MOVR Data Hub has the power to transform health outcomes, accelerate drug development and drive clinical research across multiple neuromuscu

This study will evaluate the efficacy, safety, and pharmacokinetics of prasinezumab compared with placebo in patients with early Parkinson's disease (PD).